D M Moore|P H Raven - JoVE Visualize

Showing results (91-100 of 109) with videos related to

Pageof 11

Sort By:

BMJ Open|May 15, 2020

Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, CanadaAndrea Bever, Kate Salters, Clara Tam, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1985

Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type AG N Weddell, D G Yansura, D J Dowbenko, et al.

Sexually Transmitted Infections|November 18, 2016

Does age matter? Sexual event-level analysis of age-disparate sexual partners among gay, bisexual and other men who have sex with men (GBM) in Vancouver, CanadaK Closson, N J Lachowsky, Z Cui, et al.

Virology|April 30, 1983

Identification of amino acid and nucleotide sequence of the foot-and-mouth disease virus RNA polymeraseB H Robertson, D O Morgan, D M Moore, et al.

HIV Medicine|June 10, 2016

Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001-2012C C Cheung, E Ding, P Sereda, et al.

Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1994

The development of a client application for the collaborative social and medical services systemD M Moore, H S Gilson, Y Li, et al.

Seminars in Hematology|October 1, 1994

Retinoic acid and interferon in human cancer: mechanistic and clinical studiesD M Moore, D V Kalvakolanu, S M Lippman, et al.

HIV Medicine|August 22, 2019

Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural UgandaJ Birungi, Z Cui, S Okoboi, et al.

HIV Medicine|February 28, 2015

Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, CanadaL Lourenço, H Samji, A Nohpal, et al.

Medinfo. MEDINFO|January 1, 1995

A proposed architecture for ambulatory systems developmentG J Buffone, C A Petermann, R B Bobroff, et al.

Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:

Pageof 11

BMJ Open|May 15, 2020

Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, CanadaAndrea Bever, Kate Salters, Clara Tam, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1985

Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type AG N Weddell, D G Yansura, D J Dowbenko, et al.

Sexually Transmitted Infections|November 18, 2016

Does age matter? Sexual event-level analysis of age-disparate sexual partners among gay, bisexual and other men who have sex with men (GBM) in Vancouver, CanadaK Closson, N J Lachowsky, Z Cui, et al.

Virology|April 30, 1983

Identification of amino acid and nucleotide sequence of the foot-and-mouth disease virus RNA polymeraseB H Robertson, D O Morgan, D M Moore, et al.

HIV Medicine|June 10, 2016

Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001-2012C C Cheung, E Ding, P Sereda, et al.

Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1994

The development of a client application for the collaborative social and medical services systemD M Moore, H S Gilson, Y Li, et al.

Seminars in Hematology|October 1, 1994

Retinoic acid and interferon in human cancer: mechanistic and clinical studiesD M Moore, D V Kalvakolanu, S M Lippman, et al.

HIV Medicine|August 22, 2019

Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural UgandaJ Birungi, Z Cui, S Okoboi, et al.

HIV Medicine|February 28, 2015

Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, CanadaL Lourenço, H Samji, A Nohpal, et al.

Medinfo. MEDINFO|January 1, 1995

A proposed architecture for ambulatory systems developmentG J Buffone, C A Petermann, R B Bobroff, et al.

Pageof 11